According to Natco Pharma 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.78053. At the end of 2023 the company had a P/S ratio of 3.78.
Year | P/S ratio | Change |
---|---|---|
2023 | 3.78 | -9.1% |
2022 | 4.16 | -66.76% |
2021 | 12.5 | 50.47% |
2020 | 8.31 | 47.75% |
2019 | 5.62 | 10.32% |
2018 | 5.10 | -43.51% |
2017 | 9.03 | 66.82% |
2016 | 5.41 | -47.02% |
2015 | 10.2 | 66.74% |
2014 | 6.12 | 66.67% |
2013 | 3.67 | 62.44% |
2012 | 2.26 |